| RS1690787769 |
TTN
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS1690814987 |
TTN
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS1690853952 |
PAX8
|
Health Risk |
Pathogenic |
Congenital hypothyroidism, Congenital hypothyroidism |
| RS1690856985 |
PAX8
|
Health Risk |
Likely pathogenic |
— |
| RS1690872807 |
RAB3GAP1
|
Health Risk |
Pathogenic |
— |
| RS1690880184 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1690892137 |
SMPD1
|
Health Risk |
Likely pathogenic |
Niemann-Pick disease, type A |
| RS1690965885 |
PAX8
|
Health Risk |
Pathogenic |
Hypothyroidism, congenital |
| RS1690970101 |
PAX8
|
Health Risk |
Pathogenic |
Congenital hypothyroidism, Congenital hypothyroidism |
| RS1691026372 |
SCN1A
|
Health Risk |
Likely pathogenic |
Generalized epilepsy with febrile seizures plus, type 2 |
| RS1691030502 |
TTN
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS1691037804 |
GLS
|
Health Risk |
Likely pathogenic |
Esophageal atresia/tracheoesophageal fistula, Esophageal atresia/tracheoesophageal fistula |
| RS1691039670 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS1691048388 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS1691052813 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS1691073965 |
SCN1A
|
Health Risk |
Pathogenic/Likely pathogenic |
Severe myoclonic epilepsy in infancy, Early-infantile DEE |
| RS1691082638 |
SCN1A
|
Health Risk |
Pathogenic/Likely pathogenic |
Seizure, Early-infantile DEE |
| RS1691088488 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS1691091949 |
SCN1A
|
Health Risk |
Likely pathogenic |
Migraine, familial hemiplegic |
| RS1691093633 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS1691117338 |
TTN
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS1691154033 |
PAX8
|
Health Risk |
Likely pathogenic |
Hypothyroidism, congenital |
| RS1691155605 |
PAX8;PAX8-AS1
|
Health Risk |
Likely pathogenic |
Hypothyroidism, congenital |
| RS1691171678 |
ABCB11
|
Health Risk |
Pathogenic |
Progressive familial intrahepatic cholestasis type 2, Benign recurrent intrahepatic cholestasis type 2 |
| RS1691180795 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1691183538 |
ALS2
|
Health Risk |
Likely pathogenic |
Infantile-onset ascending hereditary spastic paralysis, Infantile-onset ascending hereditary spastic paralysis |
| RS1691231110 |
ABCB11
|
Health Risk |
Pathogenic/Likely pathogenic |
Progressive familial intrahepatic cholestasis type 2, Progressive familial intrahepatic cholestasis type 2 |
| RS1691232631 |
ABCB11
|
Health Risk |
Pathogenic/Likely pathogenic |
Progressive familial intrahepatic cholestasis type 2, Benign recurrent intrahepatic cholestasis type 2 |
| RS1691236972 |
TET3
|
Health Risk |
Conflicting classifications of pathogenicity |
TET3 deficiency, Beck-Fahrner syndrome |
| RS1691258244 |
PRSS56
|
Health Risk |
Likely pathogenic |
Isolated microphthalmia 6, Isolated microphthalmia 6 |
| RS1691301206 |
HECW2
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder with hypotonia, seizures |
| RS1691361089 |
PAX8
|
Health Risk |
Pathogenic |
Congenital hypothyroidism, Congenital hypothyroidism |
| RS1691365745 |
ABCB11
|
Health Risk |
Likely pathogenic |
Benign recurrent intrahepatic cholestasis type 2, Progressive familial intrahepatic cholestasis type 2 |
| RS1691394055 |
CUL3
|
Health Risk |
Likely pathogenic |
— |
| RS1691405349 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1691525574 |
TTN
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS1691536136 |
ABCB11
|
Health Risk |
Pathogenic |
— |
| RS1691557291 |
CHRND
|
Health Risk |
Likely pathogenic |
— |
| RS1691647986 |
RAB3GAP1
|
Health Risk |
Pathogenic |
Warburg micro syndrome 1, Warburg micro syndrome 1 |
| RS1691685791 |
RYR2
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Catecholaminergic polymorphic ventricular tachycardia 1 |
| RS1691690923 |
CHRND
|
Health Risk |
Likely pathogenic |
— |
| RS1691699883 |
CHRND
|
Health Risk |
Pathogenic/Likely pathogenic |
Congenital myasthenic syndrome 3B, Lethal multiple pterygium syndrome |
| RS1691763747 |
ABCB11
|
Health Risk |
Likely pathogenic |
Benign recurrent intrahepatic cholestasis type 2, Progressive familial intrahepatic cholestasis type 2 |
| RS1691855470 |
TTN
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS1691881913 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1691895200 |
GGCX
|
Health Risk |
Pathogenic |
— |
| RS1691898752 |
GGCX
|
Health Risk |
Pathogenic |
Vitamin K-dependent clotting factors, combined deficiency of |
| RS1691965570 |
GGCX
|
Health Risk |
Pathogenic |
Body skin hyperlaxity due to vitamin K-dependent coagulation factor deficiency, Body skin hyperlaxity due to vitamin K-dependent coagulation factor deficiency |
| RS1691972995 |
GGCX
|
Health Risk |
Conflicting classifications of pathogenicity |
Vitamin K-dependent clotting factors, combined deficiency of |
| RS1692065656 |
CHRNG
|
Health Risk |
Pathogenic |
— |
| RS1692107154 |
GGCX
|
Health Risk |
Likely pathogenic |
Vitamin K-dependent clotting factors, combined deficiency of |
| RS1692153577 |
CUL3
|
Health Risk |
Pathogenic |
NEURODEVELOPMENTAL DISORDER WITH AUTISM AND SEIZURES, NEURODEVELOPMENTAL DISORDER WITH AUTISM AND SEIZURES |
| RS1692153643 |
SCN1A
|
Health Risk |
Pathogenic/Likely pathogenic |
Severe myoclonic epilepsy in infancy, Generalized epilepsy with febrile seizures plus |
| RS1692162437 |
LOC102724058;SCN1A
|
Health Risk |
Pathogenic |
— |
| RS1692166604 |
SCN1A
|
Health Risk |
Pathogenic |
Severe myoclonic epilepsy in infancy, Early-infantile DEE |
| RS1692180906 |
PAX3
|
Health Risk |
Pathogenic |
Waardenburg syndrome type 1, Waardenburg syndrome type 1 |
| RS1692186575 |
SATB2
|
Health Risk |
Pathogenic |
Chromosome 2q32-q33 deletion syndrome, Chromosome 2q32-q33 deletion syndrome |
| RS1692187554 |
SATB2
|
Health Risk |
Conflicting classifications of pathogenicity |
Chromosome 2q32-q33 deletion syndrome, Chromosome 2q32-q33 deletion syndrome |
| RS1692190479 |
SATB2
|
Health Risk |
Likely pathogenic |
Autism spectrum disorder, Autism spectrum disorder |
| RS1692192971 |
SATB2
|
Health Risk |
Pathogenic/Likely pathogenic |
Chromosome 2q32-q33 deletion syndrome, Inborn genetic diseases |
| RS1692194381 |
SATB2
|
Health Risk |
Pathogenic |
— |
| RS1692195440 |
SATB2
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Chromosome 2q32-q33 deletion syndrome |
| RS1692195674 |
SATB2
|
Health Risk |
Pathogenic |
Intellectual disability, Intellectual disability |
| RS1692200373 |
BARD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS1692200499 |
BARD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS1692204026 |
BARD1
|
Health Risk |
Likely pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS1692211675 |
BARD1
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial cancer of breast, Malignant tumor of breast |
| RS1692216921 |
BARD1
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS1692217798 |
BARD1
|
Health Risk |
Likely pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS1692220779 |
ABCB11
|
Health Risk |
Pathogenic/Likely pathogenic |
Benign recurrent intrahepatic cholestasis type 2, Progressive familial intrahepatic cholestasis type 2 |
| RS1692227690 |
BARD1
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS1692230196 |
ABCB11
|
Health Risk |
Pathogenic |
— |
| RS1692287436 |
BMPR2
|
Health Risk |
Conflicting classifications of pathogenicity |
Pulmonary hypertension, primary |
| RS1692288591 |
BMPR2
|
Health Risk |
Pathogenic |
Primary pulmonary hypertension, Primary pulmonary hypertension |
| RS1692301420 |
BARD1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1692302934 |
BARD1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS1692304617 |
GGCX
|
Health Risk |
Pathogenic |
— |
| RS1692308262 |
BARD1
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS1692335353 |
CUL3
|
Health Risk |
Pathogenic/Likely pathogenic |
Abnormal cardiovascular system morphology, Neurodevelopmental disorder with or without autism or seizures |
| RS1692428076 |
D2HGDH
|
Health Risk |
Likely pathogenic |
D-2-hydroxyglutaric aciduria 1, D-2-hydroxyglutaric aciduria 1 |
| RS1692452265 |
CUL3
|
Health Risk |
Likely pathogenic |
— |
| RS1692452859 |
D2HGDH
|
Health Risk |
Pathogenic |
D-2-hydroxyglutaric aciduria 1, D-2-hydroxyglutaric aciduria 1 |
| RS16924759 |
FKTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A |
| RS1692479893 |
HECW2
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder with hypotonia, seizures |
| RS1692487571 |
CUL3
|
Health Risk |
Pathogenic |
NEURODEVELOPMENTAL DISORDER WITHOUT AUTISM OR SEIZURES, NEURODEVELOPMENTAL DISORDER WITHOUT AUTISM OR SEIZURES |
| RS1692492382 |
ALS2
|
Health Risk |
Pathogenic |
Infantile-onset ascending hereditary spastic paralysis, Infantile-onset ascending hereditary spastic paralysis |
| RS1692508715 |
CNGA3
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinal dystrophy, Achromatopsia 2 |
| RS1692509021 |
CNGA3
|
Health Risk |
Pathogenic |
Achromatopsia 2, Achromatopsia 2 |
| RS1692543303 |
SCN1A
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, Developmental and epileptic encephalopathy |
| RS1692546613 |
SCN1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Early-infantile DEE, Early-infantile DEE |
| RS1692577292 |
SCN1A
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, Developmental and epileptic encephalopathy |
| RS1692581621 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS1692586014 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Inborn genetic diseases |
| RS1692586274 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS1692588792 |
CUL3
|
Health Risk |
Pathogenic/Likely pathogenic |
CUL3-related disorder, CUL3-related disorder |
| RS1692619276 |
STAT1
|
Health Risk |
Likely pathogenic |
Immunodeficiency 31B, Autoimmune enteropathy and endocrinopathy - susceptibility to chronic infections syndrome |
| RS1692619812 |
PAX3
|
Health Risk |
Likely pathogenic |
Waardenburg syndrome type 1, Waardenburg syndrome type 1 |
| RS1692621563 |
PAX3
|
Health Risk |
Pathogenic |
— |
| RS1692623308 |
PAX3
|
Health Risk |
Pathogenic |
Waardenburg syndrome type 1, Waardenburg syndrome type 1 |
| RS1692739030 |
CNGA3
|
Health Risk |
Pathogenic |
Achromatopsia, Achromatopsia |